Your session is about to expire
← Back to Search
Red Blood Cell Survival Study for Sickle Cell Disease
Study Summary
This trial is measuring the survival of transfused red blood cells in people with sickle cell disease who are receiving chronic transfusion therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently taking hydroxyurea.I expect to stop my current cancer treatment within 2 months.I have been on hormone therapy for at least 3 months.I have sickle cell disease, either HbSS or HbSβ0 thalassemia.You are taking large doses of biotin supplements or raw egg supplements.I have not had, nor plan to have, a red blood cell exchange in the last or next 3 months.
- Group 1: Biotin labeled Red Blood Cells
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has there been any previous research conducted using Biotin Labeled Red Blood Cells?
"Currently, 5 trials are active researching Biotin Labeled Red Blood Cells - one of which is at the critical Phase 3 stage. While the main research hub for this treatment is located in Bethesda, Maryland, there are 7 additional sites running their own investigations."
How many subjects are currently taking part in this experiment?
"Indeed, the data hosted on clinicaltrials.gov attests that this medical experiment is actively seeking volunteers. It was initially posted in October 2021 and subsequently updated later that month. 40 participants must be sourced from 3 different sites to fulfill its requirements."
Is this medical research still open to recruitment?
"Affirmative. Clinicaltrials.gov provides information that this clinical trial, initially posted on October 29th 2021, is now searching for participants. A total of 40 individuals need to be enrolled from 3 distinct medical centres."
Has the utilization of Biotin Labeled Red Blood Cells been ratified by the FDA?
"Since this is a Phase 1 trial and there is only minimal evidence of safety and efficacy, the risk associated with Biotin Labeled Red Blood Cells was assessed as low (level 1) by our team at Power."
Share this study with friends
Copy Link
Messenger